PUBLISHER: Grand View Research | PRODUCT CODE: 1986360
PUBLISHER: Grand View Research | PRODUCT CODE: 1986360
The global myopia and presbyopia treatment market size was valued at USD 21.8 billion in 2025 and is estimated to reach USD 45.4 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. The myopia and presbyopia treatment market is experiencing steady growth, driven by the rising global burden of vision disorders, increasing screen time, aging populations, and growing awareness of eye health.
Lifestyle changes such as prolonged digital device usage and reduced outdoor activity are significantly contributing to the increase in refractive errors, especially among children and working adults. According to the World Health Organization, at least 2.2 billion people globally have a vision impairment or blindness, with a large proportion being preventable or treatable. These factors, combined with improved access to eye care services and technological advancements, are accelerating demand for effective treatment solutions.
Myopia (nearsightedness) is a condition where distant objects appear blurred due to elongation of the eyeball or improper focusing of light on the retina. It is increasingly common among children and young adults. Presbyopia, on the other hand, is an age-related condition that typically affects individuals over 40 and is caused by the gradual loss of the eye's ability to focus on nearby objects. Both conditions require vision correction through glasses, contact lenses, surgery, or emerging pharmacological treatments. The increasing prevalence of these conditions is creating sustained demand for a wide range of treatment options.
One of the key drivers of market growth is the rapid increase in myopia prevalence worldwide. A recent global analysis published in the British Journal of Ophthalmology and reported by The Guardian in September 2024 highlights that myopia cases are increasing rapidly worldwide, with projections suggesting that over 740 million children and teenagers could be affected by 2050, and global prevalence may reach nearly 40% among young populations. This surge is particularly evident in Asia Pacific countries, where urbanization, education patterns, and digital lifestyles are contributing to the early onset and progression of myopia. As a result, there is a growing demand for myopia management solutions such as specialty lenses, orthokeratology, and low-dose atropine therapy.
Global Myopia And Presbyopia Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global myopia and presbyopia treatment market report based on myopia treatment type, presbyopia treatment type, and region: